SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7%
Wed, 14 Nov

SUN PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m66,50372,24269,376-4.0%4.3%
Other incomeRs m2,5481,9983,51275.8%37.8%
TurnoverRs m69,05274,23972,888-1.8%5.6%
ExpensesRs m52,74756,17554,064-3.8%2.5%
Gross profitRs m13,75616,0673,168-80.3%-77.0%
DepreciationRs m3,5874,0164,2656.2%18.9%
InterestRs m1,5741,3091,295-1.0%-17.7%
Profit before taxRs m11,14412,7391,119-91.2%-90.0%
TaxRs m1,1141,6392,18933.6%96.5%
Profit after taxRs m10,03011,101-1,070-109.6%-110.7%
Gross profit margin%20.722.24.6
Effective tax rate%10.012.9195.6
Net profit margin%14.515.0-1.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 4.3% on a year-on-year (YoY) basis. The expenses were up by 2.5% YoY during the same period.
  • The company's operating profit declined by 77.0% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 4.6% in 2QFY19 as against 20.7% in 2QFY18.
  • Depreciation charges increased by 18.9% and finance costs declined by 17.7% YoY, respectively.
  • Other income increased by 37.8% YoY during the quarter.
  • Net profit for the quarter declined by 110.7% YoY. Net profit margins during the quarter declined from 14.5% in 2QFY18 to -1.5% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 4.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.8% QoQ during the same period.
  • The company's operating profit declined by 80.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 4.6% in 2QFY19 as against 22.2% in 1QFY18.
  • Net profit for the quarter declined by 109.6% QoQ, while net profit margins declined from 15.0% in 1QFY18 to -1.5% in 2QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 526.2 to Rs 534.4, registering a Gain of Rs 8.2 or around 1.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,308.6 (down 1.1%). Over the last one year it has moved up from 13,727.7 to 14,308.6, a gain of 581 points (up 4.2%).

Overall, the S&P BSE SENSEX is up 6.6% over the year.

Current Valuations

At the current price of Rs 534.4, the price to earnings (P/E) ratio of SUN PHARMA stands at 43.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.4 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

I Made a Killing in the Markets this Week... Here's How(Profit Hunter)

Jan 10, 2020

How we made a killing in the markets amidst geopolitical tension and war mongering.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Jan 17, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS